Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC

Clinical trial NCT00880334 · COMPLETED

Trial details

NCT number: NCT00880334
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Transitional Cell Carcinoma Bladder Cancer

Start date: 2006-09-01
Primary completion: 2013-12-01
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.